GMP update Spectral Medical Inc. EDT-TSX May 30, 2017 Revised trial data shows significant potential Spectral announced it has filed its fourth and final module of its PMA application with the FDA. …
Spectral Files Final PMA Module for Toraymyxin(TM) With FDA TORONTO, ONTARIO--(Marketwired - May 30, 2017) - Spectral Medical Inc., ("Spectral" or the "Company"), (TSX:EDT), a Phase III company …